Harle Tsu
Marketed as hybrid. That label describes how it is sold, not its chemistry — the research is clear that it does not predict much.
Across 47 laboratory results, Harle Tsu tested between 0.4% and 23.2% THC, with a median of 17.3%. Most sites print a single number here. The spread is the more useful fact.
Laboratory chemistry
Every figure is a median across real lab results, with the middle 80% of those results beside it. A wide range means the same name tested very differently batch to batch.
| Cannabinoid | Median | Middle 80% | Samples |
|---|---|---|---|
| THC | 17.3% | 0.4% to 23.2% | 47 / about typical |
| CBD | 8.43% | 0.05% to 12.89% | 35 / above typical |
| CBG | 0.93% | 0.26% to 2.25% | 38 / above typical |
| CBN | 0.00% | 0.00% to 0.06% | 25 / about typical |
| CBC | 0.06% | 0.00% to 0.19% | 25 / above typical |
| THCV | 0.00% | 0.00% to 0.02% | 12 / about typical |
| Terpene | Median | Middle 80% | Samples |
|---|---|---|---|
| Myrcene | 0.36% | 0.18% to 0.68% | 19 / about typical |
| Limonene | 0.04% | 0.00% to 0.07% | 18 / below typical |
| Caryophyllene | 0.09% | 0.04% to 0.21% | 19 / below typical |
| Terpinolene | 0.08% | 0.00% to 0.38% | 19 / above typical |
| Pinene | 0.15% | 0.05% to 0.34% | 19 / about typical |
| Linalool | 0.02% | 0.00% to 0.04% | 19 / below typical |
| Humulene | 0.04% | 0.01% to 0.07% | 18 / below typical |
| Ocimene | 0.01% | 0.00% to 0.11% | 19 / about typical |
| Bisabolol | 0.02% | 0.00% to 0.07% | 18 / about typical |
| Nerolidol | 0.00% | 0.00% to 0.04% | 19 / about typical |
What this page does not tell you
- Whether the jar in your hand matches these numbers. Strain names are not standardised, certified or regulated. Research has found samples sharing a name that were as chemically distant from each other as samples with different names.
- How it will make you feel. This site holds no effect data, because no source publishes per-strain effect rates under a licence that permits reuse. An empty column is better than a borrowed guess.
- Anything medical. These are measurements, not claims about what cannabis does to a condition.
Sources
Where two sources cover the same analyte, the figure above is pooled over their combined samples rather than averaged — a median of two medians is not a median. Each source's own sample count is shown in the table.
- Smith, Vergara, Keegan & Kane (2022), The phytochemical diversity of commercial Cannabis in the United States, PLOS ONE · lab · CC0-1.0
Tried this one?
No one has reported on this strain yet. Yours would be the first. Effect data on this site comes entirely from people who used it, because no source of per-strain effect rates can be licensed at any price. Percentages appear once a strain has enough reports to be worth one.